A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis
Clinical trial NCT03313180 · COMPLETED
Trial details
- NCT number
- NCT03313180
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2023-01-25
- Enrollment
- 444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.